137 related articles for article (PubMed ID: 20669179)
1. Coagulopathy in a patient with nephrotic syndrome.
Ghanny S; Ross C; Chan AK; Chan HH
Am J Hematol; 2010 Sep; 85(9):708-10. PubMed ID: 20669179
[No Abstract] [Full Text] [Related]
2. Coexistence of primary AL amyloidosis and POEMS syndrome: efficacy of melphalan-dexamethasone and role of biochemical markers in monitoring the diseases course.
Adami F; Briani C; Binotto G; Altinier S; Tarantini G; Semenzato G
Am J Hematol; 2010 Feb; 85(2):131-2. PubMed ID: 20029992
[No Abstract] [Full Text] [Related]
3. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
4. A rare complication of monoclonal gammopathy.
Nasr SH; Lobritto SJ; Lauring BP; Arend LJ; D'Agati VD; Markowitz GS
Am J Kidney Dis; 2002 Oct; 40(4):867-71. PubMed ID: 12324928
[No Abstract] [Full Text] [Related]
5. [Primary amyloidosis associated to severe factor X deficiency].
Pérez Martínez J; Llamas F; López Montes A; Massó P; Poblet E; López Rubio E; Gallego E; Gómez Roldán C
Nefrologia; 2004; 24(5):493-8. PubMed ID: 15648909
[TBL] [Abstract][Full Text] [Related]
6. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
Colucci G; Alberio L; Jahns M; Keller P; Steiner S; Rüsges-Wolter I; Lämmle B
Thromb Haemost; 2009 Dec; 102(6):1285-7. PubMed ID: 19967165
[No Abstract] [Full Text] [Related]
7. [Disseminated intravascular coagulation and the course of hemorrhagic fever with nephrotic syndrome during treatment with acetylsalicylic acid].
Bunin KV; Abdurashitov RF; Muftakhova AM; Arslangareeva ZN
Ter Arkh; 1980; 52(4):84-8. PubMed ID: 6105726
[No Abstract] [Full Text] [Related]
8. [Therapy options in systemic AL-amyloidosis with renal involvement].
Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
[TBL] [Abstract][Full Text] [Related]
9. Route of vitamin K administration for elevated INRs in the acute inpatient setting.
Mersfelder TL
Med Health R I; 2005 Dec; 88(12):441-2. PubMed ID: 16408720
[No Abstract] [Full Text] [Related]
10. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
[TBL] [Abstract][Full Text] [Related]
11. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
Denas G; Cucchini U; Iliceto S; Pengo V
Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
[No Abstract] [Full Text] [Related]
12. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
13. A case of primary systemic amyloidosis.
Tanaka K; Tomino Y; Kika K; Tanabe T; Nomoto Y; Sakai H; Moriuchi T; Tsutsumi H
Tokai J Exp Clin Med; 1985 Oct; 10(5):491-7. PubMed ID: 3837399
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of coagulation in the primary nephrotic syndrome and nephrotic syndrome secondary to renal amyloidosis].
Ben Maïz H; Ayed K; Kheder A; Kastalli R; Kouki F; EL Matri A; Ben Ayed H
J Urol Nephrol (Paris); 1979 Dec; 85(12):840-5. PubMed ID: 554868
[No Abstract] [Full Text] [Related]
15. Recovery of acute renal failure and nephrotic syndrome following autologous stem cell transplantation for primary (AL) amyloidosis.
Snanoudj R; Mamzer-Bruneel MF; Hermine O; Grunfeld JP; Chauveau D
Nephrol Dial Transplant; 2003 Oct; 18(10):2175-7. PubMed ID: 13679499
[No Abstract] [Full Text] [Related]
16. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
Strengers PF; Drenth JC
Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
[TBL] [Abstract][Full Text] [Related]
17. [Coagulation tests].
Rasi V
Duodecim; 1997; 113(13):1263-70. PubMed ID: 10622131
[No Abstract] [Full Text] [Related]
18. Alpha 2-plasmin inhibitor and its deficiency states.
Saito H
J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
[No Abstract] [Full Text] [Related]
19. [Sweet's syndrome and multiple myeloma].
Borbujo J; de Lucas R; Manzano R; Casado M
Med Clin (Barc); 1996 Mar; 106(9):354-5. PubMed ID: 8667704
[No Abstract] [Full Text] [Related]
20. Nephrotic syndrome secondary to amyloidosis.
Kneipp S; Himmelstein SB
Nurse Pract; 2000 Jun; 25(6 Pt 1):78, 81, 85-6 passim. PubMed ID: 10884998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
